Glucose Metabolism in Cancer: The Saga of Pyruvate Kinase Continues
- 1 March 2018
- journal article
- editorial
- Published by Elsevier in Cancer Cell
- Vol. 33 (3) , 337-339
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell GrowthCancer Cell, 2018
- A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural ProductCell Metabolism, 2017
- PKM2, cancer metabolism, and the road aheadEMBO Reports, 2016
- The Warburg Effect: How Does it Benefit Cancer Cells?Trends in Biochemical Sciences, 2016
- Pyruvate Kinase Isoform Expression Alters Nucleotide Synthesis to Impact Cell ProliferationMolecular Cell, 2015
- Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting stepeLife, 2014
- Lost in Transition: Start-Up of Glycolysis Yields Subpopulations of Nongrowing CellsScience, 2014
- PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor CellsCell, 2013
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growthNature, 2008
- p53: oncogene or anti-oncogene?Genes & Development, 1990